Friday, 23 June 2017

Lacrimal Cannulae Market - Global Industry Volume and Region Analysis - 2024

The lacrimal irrigation and dilation are generally performed in hospital. However, with practice and care, the procedure can be carried out by an optometrist or general physician. Several dilators and cannulas are available for lacrimal dilation and irrigation, for example stainless double-ended type. Lacrimal dilation may be used prior to syringing and inserting punctum plugs. It also provides relief for short time from stenosis of the punctum. Lacrimal syringing and irrigation of lacrimal system dislodges intra-canalicular punctum plugs. The canaliculus and punctum may require dilation prior to the procedure. Lacrimal cannula is attached to a disposable syringe filled with saline and plunger removed. The cannula is inserted into the vertical canaliculus and the plunger is pressed down to irrigate the lacrimal duct. In addition, the procedure is efficacious for treating congenital nasolacrimal duct obstruction. The ease of process and effective results along with low cost of the product is anticipated to drive the global lacrimal cannulae market.


Lacrimal cannulae is an ophthalmic instrument used for irrigation and probing of the lacrimal duct. Irrigation and probing is a procedure used to evaluate the structure and functional status of the lacrimal drainage system. In case of trauma, it is helpful to look for the presence of canalicular injury. It is also used for overflow tearing known as epiphora due to either overproduction of tears or inadequacy of lacrimal drainage system. Lacrimal Cannulae used in Lacerations of the canalicular system. The canaliculi are several small ducts in the eye through which tear drains. The probing and irrigation is performed whenever the analysis of the lacrimal drainage system is indicated.

The lacrimal cannulae market has been segmented based on product, end-user, and region. In terms of product type, the market has been categorized into curved lacrimal cannula, straight lacrimal cannula, and others (pediatric lacrimal flush cannula, etc.). Based on end-user, the market has been classified into hospitals, ophthalmic clinics, and ambulatory centers. Typically, procedures such as lacrimal syringing are performed in hospitals. Hence, the hospitals segment accounts for the largest share of the market. General practitioners also use cannulas with a little practice and care.

In terms of region, the lacrimal cannulae market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are likely to dominate the lacrimal cannulae market. Factors driving the growth of the lacrimal cannulae market in North America are increasing prevalence of eye diseases among the geriatric and diabetic population. Additionally, technological developments in the field of ophthalmic surgical devices and increasing awareness among the population about surgical treatments of various retinal diseases are boosting the growth of the lacrimal cannulae market in North America. Europe held the second largest share of the lacrimal cannulae market. Asia Pacific is the most progressive region for the lacrimal cannulae market. Increasing health care awareness and per capita income are likely to drive the market in Asia Pacific. Large population base, greater initiatives taken by governments to promote health care, and robust economic growth are the factors attributed to the high growth in the region. Moreover, improving consumer awareness about eye care and better disease management are projected to propel the lacrimal cannulae market in Asia Pacific.

Major players in the lacrimal cannulae market are Medtronic, B. Braun Melsungen AG, Conmed, Cook Medical, Inc., Smiths Medical, and Devilbiss Healthcare, among others. Regional players also account for a significant share of the lacrimal cannulae market. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20432

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Digital Companion Diagnostics Market By Analysis of Major Industry Segments 2016 - 2024

The demand for personalized medicine has been on a rise since the significant development in genomics research and biomarkers. This can be attributed to the efficiency and target-specific nature of personalized medicine with better patient outcomes. In addition, the targeted therapies have minimal or no side effects compared to the conventional therapies. With the paradigm shift in the drug discovery and development process, pharmaceutical companies are shifting their focus toward the development of novel targeted therapies (genotype or phenotype specific therapies). The adoption of this paradigm shift marked the gradual termination of traditional blockbuster model. Hence, these factors increase the demand and uptake of personalized medicine which in turn drives the growth of the companion diagnostics market. Increase in the number of cancer incidence, demand for personalized medicine, and reduction in drug development cost have contributed to augment the growth of the digital companion diagnostics market. However, poor reimbursement policies, and longer developmental and approval phase are factors that are restraining the growth of the market.


Companion diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.

Companion diagnostics help in cost reduction for drug manufacturers by narrowing the target patient population who are likely to benefit from the targeted therapy. These tests enable physicians to rule out therapeutic options which are not likely to be as effective as a particular targeted drug, and thus eliminate the need for use of higher-priced cancer therapeutics and other unnecessary treatments. The consideration of a defined patient population and resultant higher efficacy of targeted therapeutics further increase the chances of the drug’s approval and aid in streamlining of the drug development process (such as fasten the approval process). In addition, companion diagnostics are important to rule out the possibility of side effects and alleviate health care costs related to management of side effects.

The market for digital companion diagnostics can be segmented on the basis of technology, disease indication, end-user, and geography. Based on technology, it is segmented into molecular diagnostics and immunohistochemistry. The molecular diagnostics segment is further sub-segmented into PCR, in situ hybridization, and next generation sequencing. This segment is anticipated to be a fast growing market due to advancement in technology, adoption of precise and accurate techniques by users, and reduction of cost and time associated with use of these methods.

Based on disease indication, the market is segmented into breast cancer, melanoma, lung cancer, colorectal cancer, and infectious disease. The breast cancer segment is estimated to hold a large market size during the forecast period. The major factors fueling growth of this market are rise in global incidence rates of breast cancer, shift toward development of targeted therapies, and increase in acceptance level of the test due to the enhanced specificity and efficiency.

Based on end-user, the market is segmented into hospitals, pharmaceutical companies, and laboratories. Based on geography, the market for digital companion diagnostics has been distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to dominate the market due to increase in health care expenditure and rise in demand for personalized treatment.

Key potential players operating in the digital companion diagnostics market are Qiagen N.V., Agilent Technologies, Inc., Agendia N.V., Life Technologies Corporation, GE Healthcare Ltd., Roche Holdings AG, Abbott Laboratories, and Genomic Health, Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20603

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Competitive Landscape for Global Transplant Diagnostics Market by Segments - 2026

Global Transplant Diagnostics Market: Overview

With increase in incidence of chronic diseases that can lead to organ failure, the global transplant diagnostics market is expected to only grow further in future. Transplant diagnostics in simpler terms is a test done to ascertain the compatibility between the recipient and donor of organ before or after transplant. 

Based on technology, the global transplant diagnostics market can be segmented into molecular assays and non-molecular assays. The molecular assay technologies segment can be further segmented into sequencing based and PCR based. In terms of products and services, market can be classified into reagents & consumables, instruments, and software and services. On the basis of application, the global transplant diagnostics market can be categorized into diagnostic applications and research applications. The diagnostic applications segment can be further segmented into blood profiling, histocompatibility testing, infectious disease diagnostics, and research applications. 


The report offers an inclusive outline of various factors contributing to the expansion of the global transplant diagnostics market. It also delivers insights into challenges that the market could face over the forecast period. The dominant trends in overall market operations are also examined in the report in detail. 

Global Transplant Diagnostics Market: Trends and Prospects

The rise of the global transplant diagnostics market can be accredited to various factors such as technological advancements in the field of genetics, coupled with increasing responsiveness among healthcare professionals about the benefits presented by molecular assay techniques and increasing number of tissue, solid organ, and stem cell transplantation procedures. However, expensive transplant diagnostic products, inadequate medical reimbursements for organ donation and transplant procedures, and unwillingness for organ donation across developing and comparatively lesser developing economies are acting as obstacle for the growth of the market.  

Based on products and services, the instruments segment is projected to hold a large market share. Factors such as increasing awareness regarding benefits offered by genome-based donor-recipient profiling, increasing commercialization of innovative transplant diagnostic instruments, ongoing technological advancements in the field of transplant diagnostics, and increasing awareness are driving the growth of this market. 

The diagnostic applications segment is the key contributor to the market share, and is expected to lead the market in the forecast period. Advanced technology and increasing investments are a few factors driving the market growth. The molecular assay technologies segment shows a promising growth, expected to register a high CAGR over the forecast period. 

Global Transplant Diagnostics Market: Regional Overview

On the basis of geography, the global market of transplant diagnostics can be divided into Asia Pacific, Europe North America, and Rest of the World. Due to a large pool of geriatric population Asia Pacific is a potential market for transplant diagnostics. In addition, growing awareness related to transplant diagnostic procedures, escalating incidence of chronic and infectious diseases, and continuously rising healthcare expenditure are a few of the factors that can be attributed to the growth of this region. To supplement growth opportunities, leading players are venturing into this promising market. 

The growing responsiveness for organ donation in European countries has resulted in increased number of living organ donors, thereby driving the market growth in Europe. 

Global Transplant Diagnostics Market: Competitive Landscape

The report profiles some of the prominent competitors operating in the market. It also provides insights into the challenges and opportunities that the companies are projected to witness in the coming years. Some of the players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Immucor, Inc., bioMérieux S.A., Bio-Rad Laboratories, Inc., Becton Dickinson and Company, CareDx, and GenDx.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20225

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Portable X-ray and CT Scan Devices Market By Geography Products Analyzers 2016 - 2026

The global portable x-ray and CT scan devices market is divided on the basis of product type into the following categories: x-ray devices, mobile x-ray devices, handheld x-ray devices, and CT scan devices, among which mobile x-ray devices were the dominant segment in 2015 and are predicted to display a steady growth rate over the forecast period. This is attributed to the increasing global demand for bedside imaging and core diagnostics. In addition, they eliminate the requirement for dedicated radiology departments in healthcare institutions, leading to cost reduction and increased profitability. Handheld x-ray devices are estimated to display a rapid growth rate over the forecast period owing to their high levels of mobility and maneuverability. Based on technology, the global portable X-Ray and CT scan devices market is segregated intothe following divisions: analog, CT scan devices, digital radiography, computed radiography, medium slice scanners, low slice scanners, and high slice scanners. Medium slice scanners led the market, accounting for a share of approximately 60% in 2015, and are projected to develop substantially over the forecast period due to their high image resolution. Digital radiography is calculated to grow considerably over the forecast period owing to the growing global demand for filmless x-ray and PACS radiology devices.


Portable x-ray and CT scan devices are used to diagnose patients who are bed-ridden and possess limited or no body mobility due to a host of disabilities and illnesses. These devices use wireless communication interfaces and are equipped with the ability to share data. They also feature an extended battery life for prolonged usage.Portable x-ray and CT scan devices use various types of wireless network communications such as WMAN, WLAN, WWAN, and WPAN. They employ the semiconductor technology and are capable of imaging, diagnostics, monitoring patients, and providing therapy. Portable x-ray and CT scan devices are paired with a PACS machine which is connected with or without a wire to a computer which enables it to view and capture images instantly. These devices provide a platform to update and maintain health records by tracking the health conditions of patients. In home care environments, portable x-ray and CT scan devices have a lot to offer in terms of treatment and health monitoring.

Major drivers of the global market for portable X-Ray and CT scan devices include the increasing rate of cardiovascular diseases and cancer, the surge in the global geriatric population, and the growing demand for home-based healthcare diagnostics. High acquisition and establishment costs, however, are major challenges.

Geographically, the global market is distributed over North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America held the dominant share in 2015 and is predicted to grow steadily over the forecast period, owing to extensive investments in the healthcare sector, the sophisticated nature of the region’s healthcare infrastructure, and its reimbursement framework. Asia Pacific is likely to witness a rapid growth rate over the forecast period on account of the improving health care infrastructure and technological advancements in China and India.

Key players in the global market include Aribex, GE Healthcare, Hitachi Medical, MinXray, Philips Healthcare, Siemens Healthcare, and Varian Medical Systems.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20036

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Medical Tapes Market Global Industry Volume By Region 2016 - 2026

Global Medical Tapes Market: Overview 

The introductory part of the report outlines terms and terminologies, and classifications that are relevant to the medical tapes industry. This is followed by a detailed overview of factors influencing the growth of the medical tapes market along with details of trends, drivers, restraints, and opportunities. The report concludes with a competitive landscape of the global medical tapes market to provide the audience with a dashboard view of key players operating in this market.

Medical tapes, also known as surgical tapes, are available in several types for securing the bandages and dressings on wounds. Medical tapes are also used for preventing sports injuries and for securing IV drips used for the treatment of healthcare conditions.


The global medical tapes market can be segmented by product type, distribution channel, application, and region. 
The report analysis demonstrates the current market dynamics and trends and how they are expected to influence the growth of the global medical tapes market in the future. The report heavily relies on primary and secondary research to ascertain parameters such as market size, top products, top industry players, industry associations etc. 

Global Medical Tapes Market: Trends and Opportunities 

The rising incidence of hospital-acquired infections (HAIs), concerns about patient safety among healthcare providers, the launch of newer products from manufacturers, and introduction of single-patient use products are primarily driving the global market for medical tapes. In addition, increasing awareness about the use of medical tapes among physicians and patients for treatment efficacy, and the increasing incidence of burns, wounds, and injuries are bolstering the market’s growth. The focus of product manufacturers to introduce differential products for enhanced safety and wider applications in a bid to increase their market share is also favoring the growth of the global medical tapes market. 

The silk cloth product segment is expected to expand at an accelerated pace and is expected to emerge as the largest segment in the overall market during the forecast period. The wide application base of silk cloth medical tapes for a range of medical conditions and their easy availability is contributing to the growing popularity of this product segment. The silicone tapes product segment is anticipated to be most preferred over other product types among both physicians and patients globally during the forecast period. 

Wounds and injuries application segment is expected to account for the highest revenue as previously displayed in the recent past. The hospital distribution channel segment is expected to account for a significant revenue contribution to the global market on account of the increased number of hospital admissions. 

Global Medical Tapes Market: Regional Outlook 

The global medical tapes market can be broadly classified into the regional segments of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Amongst these, Asia Pacific is expected to lead the overall market holding the maximum share in the near future. North America and Asia Pacific are expected to collectively account for a significant revenue of the market during the forecast period. 

Global Medical Tapes Market: Competitive Landscape 

Some of the companies having a significant presence in the global medical tapes market are 3M, Paul Hartmann AG, Andover Healthcare Inc., Medtronic Plc, Johnson & Johnson, Scapa Group PLC, and Ad Tape & Label. These players are focused on strengthening their market presence globally by entering new markets and by introducing novel and cost-effective products. This, in turn, is expected to translate into business growth for leading players in the global medical tapes market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19886

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Competitive Landscape for Global Cone Calorimeter Market by Segments - 2026

Cone calorimeter is an instrument used in the field of fire testing. Cone calorimeter test is the best method to measure the reaction of material to fire. The instrument is used to determine the behavior of material. The cone calorimeter test makes possible to evaluate smoke production, ignitability, toxic gas production, and combustibility of material. The method reacquires minimum sample and this makes the cone calorimeter an attractive and ideal tool during early development and production stages. A sample is loaded on a load cell which measures the mass loss rate of the sample during combustion. The heated sample ignites the volatile gas and an electrical spark. The pressure, smoke, and temperature reading is recorded manually or automatically by the device to calculate heat release rate. The combustion gases are then collected in the accompanying duct and exhaust hood. The cone calorimeter is a cost effective test as it requires small amount of sample and saves cost of transportation of material. This is a safe, fast, and accurate method, and it can test multiple samples at one time. Apart from product development, the cone calorimeter test can be used as quality control tool. 


The cone calorimeter system contains basic units such as conical heater, temperature controller, specimen holder, load cell, exhaust system, oxygen analyzer, and heat flux meter. The system is also embedded with software and data acquisition unit. Mass loss calorimeter, carbon dioxide and monoxide are the optional analyzer for the cone calorimeter test. 

The cone calorimeter market has been segmented based on type of specimen, application, end-user, and region. In terms of type of specimen, the market has been segmented into soil, liquid, and others. The cone calorimeter test is widely used for any type of sample such as cables, marine product, railway product, furnishing, and building products. The wide choice of samples make this tool more applicable. This is likely to fuel the growth of the cone calorimeter market during the forecast period. Based on application, the market has been segmented into diagnostics, research etc. 

In terms of end-user, the cone calorimeter market has been segmented into pharmaceutical & biotechnology industry, textile industry, polymer industry, and others. Cone calorimeter is widely used in the pharmaceutical industry due to rising research and development activities. Increasing demand for research is expected to boost the growth the segment during the forecast period. The cone calorimeter test is also used in drug development. The tool is easy to handle and is sophisticated in nature, possesses variety of test parameters by single method. The pharmaceutical & biotechnology segment is expected to witness robust growth during the forecast period. The cone calorimeter test is also used in independent testing laboratories and government labs for the purpose of diagnosis. 

In terms of region, the cone calorimeter market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe dominate the global cone calorimeter market. Rising research is the key factor driving the cone calorimeter market in North America. Asia Pacific is the most progressive market for cone calorimeter due to cost effectiveness nature of test. Factors such as availability of system, small sample requirement, low cost, safe, and easy handling are the key factors likely to drive the cone calorimeter market in Asia Pacific during the forecast period. 

Major players in the cone calorimeter market are Spectro Lab Equipments, Fire Testing Technology, GBH International, Efectis, Suzhou Phinix Instrument CO., Ltd., and KOBIS Trading Corporation, among others. Increasing competition in the cone calorimeter market is likely to fuel the growth of market during the forecast period. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19736

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Thursday, 22 June 2017

Global Ophthalmic Viscosurgical Devices Market Share by Industry Research 2017 - 2025

Ophthalmic viscosurgical devices (OVDs) are used in cataract surgery as a viscoelastic solution to create and maintain space in the anterior chamber of the eye. OVDs have generally been used during phacoemulsification, implantation of intraocular lens, to protect corneal endothelium, and as a coating to surgical instruments. OVDs are transparent, gel like viscous substances having elastic properties. OVDs have properties of both fluids and solids. The differentiating feature in OVDs can be because of viscosity, pseudoplasticity, viscoelasticity, and coatability.


Rising geriatric population is a major factor driving the global ophthalmic viscosurgical devices market. The global geriatric population has increased from 9.2% in 1990 to 11.7% in 2013 and is expected to increase to 21% in 2050. Moreover, rising diabetic population and growing awareness regarding complications associated with diabetes are likely to fuel the growth of the global ophthalmic viscosurgical devices market. Diabetic people are affected with complications such as diabetic retinopathy and blindness. According to IDF, global prevalence of diabetes is projected to increase from 360 million in 2011 to 550 million by 2030. This is anticipated to propel the ophthalmic viscosurgical devices market. Additionally, high life expectancy and shift toward older average age has led to increased incidence of cataract cases and is expected to contribute to the growth of the global ophthalmic viscosurgical devices market. Along with cataract, increasing incidence of age-related macular degeneration (AMD) and glaucoma are factors driving the market. According to the National Alliance for Eye and Vision Research & National Eye Institute, an estimated 0.2 million individuals are affected with AMD in the U.S. and the number of affected individuals is expected to double during the forecast period. However, lack of awareness among people about visual health, shortage of skilled ophthalmologists, and limited availability of screening equipment in the undeveloped countries are factors likely to hamper the growth of global ophthalmic viscosurgical devices market.

The global ophthalmic viscosurgical devices market has been segmented based on product type, material used, end-user, and region. In terms of product type, the market has been segmented into cohesive OVD, dispersive OVD, and combined OVD. Cohesive OVDs are long chain, high weight, and high viscosity substance. Dispersive OVDs are short chain, low molecular weight, and have low viscosity. In terms of material used, the ophthalmic viscosurgical devices market has been segmented into sodium hyaluronate, chondroitin sulfate, and methyl cellulose. Based on end-user, the ophthalmic viscosurgical devices market has been segmented into hospitals, ambulatory surgical centers, and eye specialty clinics.

In terms of region, the global ophthalmic viscosurgical devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global ophthalmic viscosurgical devices market due to increased awareness and availability of wider treatment options in the region. The U.S. held the largest market share in North America in terms of revenue, followed by Canada. Europe is the second largest market in terms of revenue, with the U.K. and Germany accounting for major share of the market. Asia Pacific is a highly potential market, with emerging countries such as India and China. The market in the region is expected to expand at a high CAGR during the forecast period. Increasing awareness regarding treatment options and rising diabetic population with complications are likely to boost the growth of the market. Latin America and Middle East & Africa are expected to contribute to the growth of the market due to improving economy and rising awareness regarding the disorder.

Key players operating in the ophthalmic viscosurgical devices market are Abbott Medical Optics, Inc., Carl-Zeiss AG, Novartis International AG (Alcon Inc.), Johnson & Johnson Vision Care, Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., Allergan, Inc., Hyaltech Ltd., Valeant Pharmaceuticals International, Inc. (Bausch + Lomb, Inc.), CIMA Technology, Inc., and Rayner, among others. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26411

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Competitive Landscape for Global Cell-free Protein Expression Market by Segments - 2024

Cell-free protein expression, also called in vitro protein synthesis, involves the production of the desired recombinant proteins in cell lysates without using cell culture or living cells. Cell lysates produced via the breakdown and use of cellular components (eukaryotic or bacterial cells of humans or insects). Cell-free protein expression is carried out using different cell extracts such as those of E. coli (prokaryotic), rabbit reticulocytes, wheat germs eukaryotes), and insect cells. This system has many significant advantages over protein expression in living cells including the shorter duration of the process, expression of toxic proteins, isotopic labeling of proteins, optimization of protein complexes, incorporation of non-natural amino acids, optimization of protein production, and cost-effectiveness. Cell-free protein expression also allows the co-expression of multiple proteins and is easily employed for automation.


The global cell-free protein expression market is divided into the following product types on the basis of lysates used: mammalian, E. coli, wheat germs, and insect membrane. Among these, E. coli cell lysates are highly used. In terms of the expression mode, CFPS are categorized into the continuous and batch modes. The three major end-users of CFPS systems are the pharmaceutical & biotechnological industry, contract research institutes, and academic & research institutes, of which pharmaceutical companies are dominant, followed by contract research institutes.

The global CFPS market is driven by the key advantages of this system over in vivo protein synthesis such as the shorter duration required to receive the desired recombinant proteins, advanced applications in enzyme engineering, protein purification, and modification. Other factors projected to propel the market during the forecast period include the increasing demand for protein synthesis, rising activity of outsourcing pharmaceutical and biotechnological companies, and the growing number of research and academic institutes. New developments such as Protein Synthesis Using Recombinant Elements (PURE) offer opportunities for specialized applications such as in vitro protein evolution, protein micro-arrays, and protein labelling. The high cost of CFPS & reagents and low protein production rates are anticipated to restrict the global CFPS market.

Based on geography, global CFPS market is distributed over North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the market owing to the high expenditure on R&D activities and increasing demand for protein synthesis in the region. Europe and APAC are likely to display high growth rates during the forecast period as a result of the surge in R&D, biopharmaceutical companies, and demand for recombinant proteins.

Key players operating in the global CFPS market include New England Biolabs, Inc., TAKARA BIO INC., Thermo Fisher Scientific Inc., Promega Corporation., CellFree Sciences Co., biotechrabbit GmbH, Bioneer Corporation, Jena Bioscience GmbH, and Cube Biotech GmbH etc. Among these, Thermo Fisher Scientific Inc., biotechrabbit GmbH, and New England Biolabs, Inc. are the leaders. The New England Biolabs, Inc. has developed the technology PURE for CFPS and is promoting its use and application across the globe.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19595

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Post-menopausal Osteoporosis Market Global Industry Volume By Region 2016 - 2024

Osteoporosis is a progressive systemic skeletal disorder characterized by skeletal fragility, microarchitectural disruption, and low bone mass, resulting in decreased bone strength and an increased risk of fracture. Majority of post-menopausal osteoporosis occurs due to estrogen deficiency. Post-menopausal osteoporosis is a disease that ranges from asymptomatic bone loss to disabling hip fracture. Osteoporosis is a worldwide health issue because of the associated morbidity, mortality, and costs. The prevalence of the disease is not only in western countries but also in Latin America and Asia Pacific. According to World Health Organization, more than 75 million people suffer from osteoporosis fracture in Europe, Japan, and the U.S., and more than 2.3 million fractures occur annually alone in Europe and the U.S. Hip fracture is the most serious osteoporotic fracture, which results from falls, but some occur spontaneously. Women are highly affected than men, and there is an increasing incidence of the disease with age. The risk of hip fracture lies between 14% and 20% among women in the U.S. and Europe. In most cases, post-menopausal osteoporosis is a silent disease because no symptoms are seen until the fracture occurs. The combined risk for spine, hip, and forearm fracture has been estimated to be approximately 40%, which is similar to coronary artery disease. The risk of an osteoporotic fracture increases exponentially with age due to the decrease in bone density or bone mineral density (BMD) and the occurrence of other age-related accidents, e.g., increasing incidence of falls. 


Factors such as aging population, decline in estrogen levels after menopause, lifestyle changes such as smoking and alcohol consumption, and increase in bone loss after menopause are projected to drive the post-menopausal osteoporosis market globally. Mergers & acquisitions and new product innovation are another fueling factors which are expected to add value to the post-menopausal osteoporosis market. On other hand, high standards regulatory approval of any new product launch into the market, competition from the emerging alternative technologies, and intense competition from generics are estimated to hinder the growth of the market. 

The post-menopausal osteoporosis market has been segmented by treatment, distribution channel, and geography. In terms of treatment, the market is classified into vitamin D, bisphosphonates, calcitonin, hormone replacement therapy, estrogen antagonist, parathyroid hormone, and combination therapy. In terms of distribution channel, the market is classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the post-menopausal osteoporosis market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. 

Geographically, North America dominates the market due to growing number of geriatric population, and early adoption of treatment procedure, which in turn are likely to drive the post-menopausal osteoporosis market. The geriatric population represents about 14.5% of the U.S. population. According to U.S. Department of Health and Human Services by 2060, the number is expected to grow to 98 million, which is twice of 2014 geriatric population in the U.S. Europe is the second largest market due to increase in research and development activities as well as new product innovation. Asia Pacific is expected to grow at a higher rate due to rise in health care expenditure and research & development activities, along with development in medical tourism. Latin America and Middle East & Africa are projected to create large opportunities for the post-menopausal osteoporosis market owing to increase in health care insurance policies, growth in awareness among people, and shift of more number of companies toward these regions due to untapped markets. These factors are likely to add value to the Latin America and Middle East & Africa post-menopausal osteoporosis markets. 

Major players operating in this market include Amgen Inc., Clonz Biotech Pvt Ltd, Eli Lilly and Company, Enteris BioPharma, Inc., Ligand Pharmaceuticals, Inc., Merck & Co., Inc., Oncobiologics, Inc., Paras Biopharmaceuticals Finland Oy, BiologicsMD, Inc., and Radius Health, Inc. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19574

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Diabetes Care Technologies Market Global Industry Volume By Region 2016 - 2024

Global Diabetes Care Technologies, Devices and Therapeutics Market: Overview

Diabetes is a growing global concern. By 2030, approximately 438 million people will be suffering from diabetes, according to The World Diabetes Foundation. The global healthcare expenditure of about 11.6% is held by diabetes care. Presently, there are about 528.7 million people suffering from obesity, which is a key factor triggering diabetes in people.

The global diabetes care technologies, devices and therapeutics market is can be segmented on the basis of devices into blood glucose monitoring, insulin delivery, and other glucose testing devices.

The report presents a comprehensive overview of various factors contributing to the expansion of the global diabetes care technologies, devices and therapeutics market. It also offers insights into challenges that the market could face over the forecast period. The prevailing trends affecting overall market operations are also studied in the report in detail.


Global Diabetes Care Technologies, Devices and Therapeutics Market: Key Trends

The diabetes care market is chiefly driven by sedentary lifestyle and the rising prevalence of obesity. The cases of diabetes reported in the world have tremendously increased over the years. The escalating number of fast food chains all across the globe has added fuelled the obesity issues as well. There is a reduction seen in the physical activities – not only among the elders, but in children as well. All these factors are pushing the market for diabetes care technologies, devices, and therapeutics.

On the other hand, reimbursement issues are the main factor limiting market growth during the analysis period. Moreover, third party reimbursements are restricted to the type of coverage they provide concerning devices, diagnosis and treatment of diabetes.

Global Diabetes Care Technologies, Devices and Therapeutics Market: Regional Overview

On the basis of geography, the global diabetes care technologies, devices and therapeutics market can be classified into North America, Europe, the Middle East & Africa, Asia Pacific, and Latin America. Asia Pacific is known to lead the market for diabetes care technologies, devices and therapeutics market. The two of the most populated countries of Asia Pacific – India and China – are known to have a large pool of diabetic patients, thereby increasing the demand of the market. According to International Diabetes Federation (IDF), China had 98.1 million and India had 65.1 million adults living with diabetes in 2013. Another reason impacting the growth of the market in this region is the eating habits and sedentary lifestyle of the people.

The Middle East is also a favorable market for diabetes care technologies, devices and therapeutics, followed by North America. High obesity rate, dietary habits, and inactive lifestyle are a few factors that have led to the increase in demand growth of the market in North America. According to the Centers for Disease Control and Prevention (CDC), about one in every 10 American adults has diabetes. If the trend continues, the figure is expected to double or triple by 2050. In 2012, 13.4 million women (11.2 percent) had diabetes, according to the National Diabetes Report. About 15.5 million men (13.6 percent) had it.

Global Diabetes Care Technologies, Devices and Therapeutics Market: Key Players

The report profiles some of the prominent competitors operating in the market. It also provides insights into the threats and opportunities that the companies are expected to witness in the coming years. Some of the key players in the global diabetes care technologies, devices and therapeutics market are Takeda and Merck & Co. Ltd., Roche, Johnson & Johnson, Glaxosmithkline, Novartis International AG, Abbott Laboratories, Bayer AG, and Sanofi.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19427

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Anesthesia Endotracheal Tubes Market Analysis by Segments, Size and Forecast 2016 - 2024

Introduction of advanced technology in the medical field, which enables easy performing of critical surgeries and usage of high-quality consumables in the field are the recent trends in the global anesthesia endotracheal tubes market. However, availability of an increased number of alternative disposable devices and upcoming better options may act as a barrier for the anesthesia endotracheal tubes market. The anesthesia endotracheal tubes market has been segregated into organized and unorganized as well as global and regional players. The unorganized local market in developing countries may give a tough competition to the global players by maintaining high quality standards at reasonable pricing. The dealers in the developed market are targeting back with product innovations.


Anesthesia endotracheal tube is a tube implanted in trachea to administer anesthesia, maintain the airway passage of lungs, prevent aspiration into the lungs, and allow mechanical ventilation. It also establishes the aspiration of secretions and anticipation of the pathway of extraneous material into the tracheobronchial tree. The endotracheal tube is of two types: orotracheal tube and nasotracheal tube. The orotracheal tube is rooted through the mouth, while the nasotracheal tube is rooted through the nose into the trachea. Both are used for anesthesia management.

With the advancement of health care facilities and modern technologies, surgery of vital organs such as lungs has become easy. Anesthesia endotracheal tubes make it easy for the surgeons to sedate the patient and perform the surgical procedure. Also, these tubes are accepted and used by the patients of all age groups with breathing or lung problems. This is a major factor driving the market for anesthesia endotracheal tubes. Growing industrialization leading to rise in air pollution and habits such as smoking are responsible for increasing incidence of respiratory diseases. This can be considered as a factor propelling the anesthesia endotracheal tubes market. Rising incidence of other respiratory diseases, lung diseases, and breathing disorders also drives the market.

Based on the product type, the global anesthesia endotracheal tubes market can be segmented into: orotracheal tubes and nasotracheal tubes. Orotracheal tubes are implanted in the patient’s trachea through the mouth. Nasotracheal tubes are implanted in the trachea through the nose. These tubes are employed in the cases wherein the patient’s mouth needs to be operated.

Based on the end-user, the anesthesia endotracheal tubes market can be segmented into: hospitals & clinics and ambulatory surgical centers (ASCs).

High demand for home-based therapy and modernization in video laryngoscopes also drive the global anesthesia endotracheal tubes market. However, complications in the anesthesia delivery system, availability of a small number of skilled medical practitioners to perform critical surgeries with perfection, and growing preference to laryngeal masks over anesthesia endotracheal tubes are likely be major factors restraining the growth of the market during the forecast period.

Based on the geographical region, the anesthesia endotracheal tubes market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major market for anesthesia endotracheal tubes, due to respiratory disorder-prone lifestyle of people in the region and a large number of elderly population. Asia Pacific is an expanding market due to increase in the incidence of respiratory diseases in the region.

Some players operating in the global anesthesia endotracheal tubes market are Medline Industries, Medtronic, C. R. Bard, ConvaTec, GE Healthcare, Smiths Medical, KindWell Medical, ROYAX, Fuji Systems, Teleflex, Neurovision Medical, and Intersurgical. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19298

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Medical Composites Market Key Trends & Industry Forecast 2016 - 2024

Composite is also known as composition material or composite material. Composite material is made of two or more materials that have different chemical or physical properties, which form a new material that has different characteristics than the combined materials. The new material are produced may have many reasons such as materials which are stronger, less expensive or lighter, when it is compared to traditional materials. Composite materials have various applications in the aerospace, automotive, construction, consumer goods, defense, marine, medical, oil & gas, rail, and renewable industries. A composite material can be used for many purposes such as construction of buildings and bridges, and for structures such as boat hulls, race car bodies, bathtubs, swimming pool panels, shower stalls, storage tanks, cultured marble sinks, and imitation granite. Examples of composite material are concrete, ceramic composites, metal composites, and reinforced plastics. Composite materials have wide range of medical uses such as in surgeries, implants, artificial limbs, instrument materials, and diagnostics. 


The global medical composites market has been segmented based on product type, application, end-user, and region. In terms of product type, the market has been categorized into carbon fiber composites, ceramic matrix composites, and other composites. Carbon fiber composites have wide usage and hold the largest share of the market. Based on application, the medical composites market has been segmented into diagnostic imaging, composite body implants, surgical instruments, dental, microsphere, tissue engineering, and others. Moreover, there are various other applications of medical composites which depend on the need and requirement of the material for designing and manufacturing. Medical composites are primarily used in diagnostic imaging systems. These are highly used for patient imaging tables and for accessories used in X-ray, PET, CT, and MRI imaging system. Medical composites used in diagnostic instruments lower the weight of an instrument, which in turn offers better positioning for patients and generation of clearer images. End-users of medical composites are medical device companies, pharmaceutical companies, diagnostic imaging centers, research centers, and others. 

Geographically, the medical composites market has been classified into five regions: North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (China, Japan, Australia, India, etc.), Latin America (Brazil and Mexico), and Middle East & Africa (UAE, Saudi Arabia and South Africa). Europe was the largest market for medical composites in terms of revenue owing to high demand in diagnostic imaging components, prosthetic applications, and composite implants. Europe was followed by North America and is expected to register higher growth. Emerging markets such as Asia Pacific, Latin America, and Middle East & Africa are expected to record robust growth during the forecast period from 2016 to 2024 due to the growing health care industry and aging population. China, Brazil, and India are expected to witness strong growth due to increasing investments by government bodies to enhance health care facilities. 

Technological advancement and increase in the usage of composite materials in various medical application such as implants, diagnostics, medical equipment and accessories are the other factors likely to boost the growth of the medical composites market. The market is also witnessing certain restraints such as intense competition among existing medical composites manufacturers and frequent changes in consumer preferences. 

Major players operating in this market include 3M, DSM, Polygon Company, PolyOne Corporation, Quatro Composites, Toray Industries, Inc., Composiflex, Inc., ACP Composites, Inc., Vermont Composites, Inc., and Mitsubishi Rayon Co., Ltd. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19214

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.